vibegron OAB
Selected indexed studies
- Comparison of efficacy and safety of mirabegron and vibegron in the treatment of Overactive Bladder (OAB) in older women: A systematic review and meta-analysis. (PLoS One, 2025) [PMID:40198627]
- Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial. (World J Urol, 2024) [PMID:38431689]
- Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial. (J Urol, 2024) [PMID:38708869]
_Worker-drafted node — pending editorial review._
Connections
vibegron OAB is a side effect of
Sources
- Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial. (2024) pubmed
- Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial. (2024) pubmed
- Comparison of efficacy and safety of mirabegron and vibegron in the treatment of Overactive Bladder (OAB) in older women: A systematic review and meta-analysis. (2025) pubmed
- Vibegron in overactive bladder: a comprehensive review of efficacy, safety and patient-reported outcomes. (2025) pubmed
- Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume. (2023) pubmed
- Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA. (2022) pubmed
- Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB? (2023) pubmed
- Satisfaction and persistence with vibegron in the first 6 months of overactive bladder treatment: interim results of the phase 4, real-world COMPOSUR study. (2025) pubmed
- Evaluating vibegron for the treatment of overactive bladder. (2021) pubmed
- An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder. (2022) pubmed